trending Market Intelligence /marketintelligence/en/news-insights/trending/7n2m4nefohfwwkzjphjzha2 content esgSubNav
In This List

Dipexium Pharmaceuticals names chief medical officer

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Dipexium Pharmaceuticals names chief medical officer

New York-based drugmaker Dipexium Pharmaceuticals Inc. appointed Efthymios Deliargyris as chief medical officer.

Deliargyris was previously the chief medical adviser of the company.

Dipexium Pharmaceuticals is a late-stage pharmaceutical company, engaging in the development and marketing of antibiotics in the U.S.